Safety and Effectiveness of Sonu for Pediatric Nasal Congestion

Completed · Not applicable

Conditions studied: Nasal Congestion and Inflammations

In brief

To demonstrate the safety and effectiveness of Sonu for the treatment of pediatric patients with moderate to severe nasal congestion.

Key facts

Study ID

NCT06773013

Run by

Third Wave Therapeutics

People needed

31

Starts

2025-01-09

Expected to finish

2025-03-30

Last updated by the study team

2025-09-10

Who can join

Age: 12 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pediatric subjects between the ages of 12 to 21 years
• Present with symptoms of nasal congestion for 1 month or more prior to treatment
• Have a 24 hour reflective nasal congestion subscore of the TNSS of 2 or more on a 0 to 3 scale at the time of screening

You may not qualify if…

• Head, nasal or sinus surgery within 3 months
• Sinus infection diagnosed within the last month, or rhinitis medicamentosa
• Documented history of nasal polyposis or mass
• Pregnancy

Where it is running

• Crescendo MD — Portola Valley, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.